The Hypertension Drugs market size is USD 25.44 Billion in 2026.
The Hypertension Drugs market is projected to grow at a 4% CAGR through 2033.
The Hypertension Drugs market growth drivers include rising prevalence of hypertension, increasing adoption of advanced antihypertensive therapies, and growing availability of generic drugs.
North America is the dominating region for the Hypertension Drugs market.
Pfizer Inc., Novartis AG, AstraZeneca plc, Merck & Co., Inc., and Sanofi S.A. are some leading industry players in the Hypertension Drugs market.